Plasmapheresis in Chronic Active Antibody Mediated Rejection.

被引：0
|
作者：
Oguz, E. Gok [1 ]
Yildirim, T. [1 ]
Merhametsiz, O. [1 ]
Haspulat, A. [1 ]
Ercan, Z. [1 ]
Gursoy, G. Karaveli [1 ]
Bulut, C. [1 ]
Akoglu, H. [1 ]
Akdag, I. [1 ]
Canbakan, B. [1 ]
Ayli, D. [1 ]
机构：
[1] Ankara Diskapi Yildirim Beyazit Training & Res Ho, Dept Nephrol, Ankara, Turkey
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C3034
引用
收藏
页码：677 / 677
页数：1
相关论文
共 50 条
  • [31] Treatment of antibody-mediated accelerated rejection using plasmapheresis
    Madan, AK
    Slakey, DP
    Becker, A
    Gill, JI
    Heneghan, JL
    Sullivan, KA
    Cheng, S
    [J]. JOURNAL OF CLINICAL APHERESIS, 2000, 15 (03) : 180 - 183
  • [32] RNA-Sequencing Analysis of Kidney Allografts Reveal Heightened NK Cell Activity in Chronic Active Antibody-Mediated Rejection.
    Shah, Y.
    Varma, E.
    Rahim, S.
    Li, C.
    Snopkowski, C.
    Hughes, C.
    Dadhania, D. M.
    Salvatore, S.
    Seshan, S. V.
    Elemento, O.
    Suthanthiran, M.
    Muthukumar, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 418 - 418
  • [33] A Comparison of Plasmapheresis Methods in the Treatment of Late Antibody Mediated Rejection
    Caliskan, Y.
    Yazici, H.
    Dirim, A. B.
    Aksoy, E.
    Safak, S.
    Garayeva, N.
    Mirioglu, S.
    Yegit, O.
    Oto, O. A.
    Ozluk, Y.
    Besisik, S.
    Turkmen, A.
    Lentine, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 451 - 451
  • [34] Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection.
    Kumar, D.
    Raynaud, M.
    Halloran, P.
    Loupy, A.
    Chang, J.
    Reeve, J.
    Yakubu, I.
    Bobba, S.
    Kamal, L.
    Levy, M.
    Bhati, C.
    Kimball, P.
    King, A.
    Gupta, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 453 - 453
  • [35] TREATMENT OF ACTIVE CHRONIC ANTIBODY-MEDIATED REJECTION: DANGEROUS AND USELESS?
    Pineiro, Gaston Julio
    Rovira, Jordi
    De Sousa-Amorim, Erika
    Villarreal, Jesus Zacarias
    Sole, Manel
    Revuelta, Ignacio
    Cid, Joan
    Lozano, Miguel
    Palou, Eduard
    Campistol, Josep M.
    Oppenheimer, Federico
    Diekmann, Fritz
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 113 - 113
  • [36] Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results
    Alberto Mella
    Ester Gallo
    Maria Messina
    Cristiana Caorsi
    Antonio Amoroso
    Paolo Gontero
    Aldo Verri
    Francesca Maletta
    Antonella Barreca
    Fabrizio Fop
    Luigi Biancone
    [J]. World Journal of Transplantation, 2018, 8 (05) : 178 - 187
  • [37] HLA Class I Antibody Augments FGF-23 Induced Transplant Vasculopathy and Chronic Antibody Mediated Rejection.
    Tsai, E.
    Jin, Y.
    Wesseling-Perry, K.
    Salusky, I.
    Ettenger, R.
    Reed, E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 386 - 386
  • [38] Mouse Models That Fully Reproduce Human Acute and Chronic Antibody-Mediated Kidney Transplant Rejection.
    Chow, A.
    Pearcey, J.
    Ho, T.
    Raghuveer, A.
    Kuttikat, P.
    Zhu, L.
    Sis, B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 464 - 464
  • [39] Identification of Antibodies Reactive to Vimentin in a Rat Kidney Transplant Model of Chronic Antibody-Mediated Rejection.
    Reese, S.
    Wilson, N.
    Ptak, L.
    Sullivan, J.
    Burlingham, W.
    Djamali, A.
    Panzer, S. E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 604 - 605
  • [40] The Effects of Viral Infection on Chronic Anti-Mediated Rejection.
    Oh, B.
    Ruhil, R.
    Bulut, O.
    Kwun, J.
    Kirk, A.
    Knechtle, S.
    Iwakoshi, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 132 - 132
12345